FALLOPIAN TUBE SEROUS ADENOCARCINOMA
Clinical trials for FALLOPIAN TUBE SEROUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new FALLOPIAN TUBE SEROUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for FALLOPIAN TUBE SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo therapy targets fluid buildup in recurrent ovarian cancer
Disease control Recruiting nowThis study tests whether adding an experimental drug (APL-2) to standard immunotherapy (pembrolizumab) and/or a targeted therapy (bevacizumab) can better control fluid buildup and tumor growth in people whose ovarian, fallopian tube, or peritoneal cancer has returned. About 60 ad…
Matched conditions: FALLOPIAN TUBE SEROUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Heated chemotherapy during surgery: a new hope for ovarian cancer?
Disease control Recruiting nowThis study tests the safety of giving heated chemotherapy directly into the abdomen during surgery for advanced ovarian, fallopian tube, or peritoneal cancer. About 45 people will receive either the heated treatment after surgery or standard chemotherapy before surgery. The goal …
Matched conditions: FALLOPIAN TUBE SEROUS ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC